Burow Kristina
Insider CIK 1569248 · UBX Director · RCPT Director · MTCR Director · SNNA Director, 10% owner · VIR Director · SRRK Director, 10% owner · GOSS Director · BEAM Director · ERAS 10% owner · SANA 10% owner · BOLD Director, 10% owner · LYEL 10% owner · VERV 10% owner · DALS 10% owner · NMRA Director, 10% owner · PRME 10% owner · RAPP 10% owner · MTSR Director, 10% owner · SPTX 10% owner · KARD Director, 10% owner · ASPE 10% owner · CTY 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ASPE Aspen Neuroscience, Inc. | C Conversion deriv | 2026-11-02 | 2026-11-02 | 214,355 | — | — | 0 | SEC↗ |
| ASPE Aspen Neuroscience, Inc. | C Conversion deriv | 2026-11-02 | 2026-11-02 | 259,948 | — | — | 0 | SEC↗ |
| ASPE Aspen Neuroscience, Inc. | C Conversion deriv | 2026-11-02 | 2026-11-02 | 295,490 | — | — | 0 | SEC↗ |
| ASPE Aspen Neuroscience, Inc. | C Conversion deriv | 2026-11-02 | 2026-11-02 | 295,490 | — | — | 0 | SEC↗ |
| ASPE Aspen Neuroscience, Inc. | C Conversion deriv | 2026-11-02 | 2026-11-02 | 286,304 | — | — | 0 | SEC↗ |
| ASPE Aspen Neuroscience, Inc. | C Conversion deriv | 2026-11-02 | 2026-11-02 | 286,304 | — | — | 0 | SEC↗ |
| ASPE Aspen Neuroscience, Inc. | C Conversion deriv | 2026-11-02 | 2026-11-02 | 298,258 | — | — | 0 | SEC↗ |
| ASPE Aspen Neuroscience, Inc. | C Conversion deriv | 2026-11-02 | 2026-11-02 | 298,258 | — | — | 0 | SEC↗ |
| ASPE Aspen Neuroscience, Inc. | C Conversion deriv | 2026-11-02 | 2026-11-02 | 187,182 | — | — | 0 | SEC↗ |
| ASPE Aspen Neuroscience, Inc. | P Buy | 2026-11-02 | 2026-11-02 | 1,200,000 | $15.00 | $18.00M | 1,200,000 | SEC↗ |
| ASPE Aspen Neuroscience, Inc. | C Conversion | 2026-11-02 | 2026-11-02 | 214,355 | — | — | 1,161,074 | SEC↗ |
| ASPE Aspen Neuroscience, Inc. | C Conversion | 2026-11-02 | 2026-11-02 | 295,490 | — | — | 946,719 | SEC↗ |
| ASPE Aspen Neuroscience, Inc. | C Conversion | 2026-11-02 | 2026-11-02 | 286,304 | — | — | 651,229 | SEC↗ |
| ASPE Aspen Neuroscience, Inc. | C Conversion | 2026-11-02 | 2026-11-02 | 298,258 | — | — | 364,925 | SEC↗ |
| ASPE Aspen Neuroscience, Inc. | P Buy | 2026-11-02 | 2026-11-02 | 66,667 | $15.00 | $1.00M | 66,667 | SEC↗ |
| ASPE Aspen Neuroscience, Inc. | C Conversion | 2026-11-02 | 2026-11-02 | 259,948 | — | — | 1,393,848 | SEC↗ |
| ASPE Aspen Neuroscience, Inc. | C Conversion | 2026-11-02 | 2026-11-02 | 295,490 | — | — | 1,133,900 | SEC↗ |
| ASPE Aspen Neuroscience, Inc. | C Conversion | 2026-11-02 | 2026-11-02 | 286,304 | — | — | 838,410 | SEC↗ |
| ASPE Aspen Neuroscience, Inc. | C Conversion | 2026-11-02 | 2026-11-02 | 298,258 | — | — | 552,106 | SEC↗ |
| ASPE Aspen Neuroscience, Inc. | C Conversion | 2026-11-02 | 2026-11-02 | 187,182 | — | — | 253,848 | SEC↗ |
| ASPE Aspen Neuroscience, Inc. | P Buy | 2026-11-02 | 2026-11-02 | 66,666 | $15.00 | $1000.0K | 66,666 | SEC↗ |
| CTY CITY THERAPEUTICS, INC. | C Conversion deriv | 2026-10-19 | 2026-10-19 | 1,845,585 | — | $0 | 0 | SEC↗ |
| CTY CITY THERAPEUTICS, INC. | C Conversion deriv | 2026-10-19 | 2026-10-19 | 4,991,633 | — | $0 | 0 | SEC↗ |
| CTY CITY THERAPEUTICS, INC. | C Conversion deriv | 2026-10-19 | 2026-10-19 | 3,000,000 | — | $0 | 0 | SEC↗ |
| CTY CITY THERAPEUTICS, INC. | P Buy | 2026-10-19 | 2026-10-19 | 170,000 | $18.00 | $3.06M | 13,692,507 | SEC↗ |
| CTY CITY THERAPEUTICS, INC. | C Conversion | 2026-10-19 | 2026-10-19 | 2,027,006 | — | — | 13,522,507 | SEC↗ |
| CTY CITY THERAPEUTICS, INC. | C Conversion | 2026-10-19 | 2026-10-19 | 5,482,309 | — | — | 11,495,501 | SEC↗ |
| CTY CITY THERAPEUTICS, INC. | C Conversion | 2026-10-19 | 2026-10-19 | 3,294,900 | — | — | 6,013,192 | SEC↗ |
| BOLD Boundless Bio, Inc. | M Exercise deriv | 2026-07-01 | 2026-07-06 | 16,000 | — | $0 | 0 | SEC↗ |
| SRRK Scholar Rock Holding Corp | S Sale | 2026-07-01 | 2026-07-06 | 948 | $54.28 | $51.5K | 114,657 | SEC↗ |
| SRRK Scholar Rock Holding Corp | S Sale | 2026-07-01 | 2026-07-06 | 2,105 | $53.49 | $112.6K | 115,605 | SEC↗ |
| BOLD Boundless Bio, Inc. | S Sale | 2026-07-01 | 2026-07-06 | 16,000 | $2.49 | $39.8K | 0 | SEC↗ |
| BOLD Boundless Bio, Inc. | M Exercise | 2026-07-01 | 2026-07-06 | 16,000 | $1.03 | $16.5K | 16,000 | SEC↗ |
| KARD Kardigan, Inc. | P Buy | 2026-06-22 | 2026-06-24 | 1,250,000 | $16.00 | $20.00M | 15,042,035 | SEC↗ |
| KARD Kardigan, Inc. | C Conversion deriv | 2026-06-17 | 2026-06-22 | 1,204,000 | — | $0 | 0 | SEC↗ |
| KARD Kardigan, Inc. | C Conversion deriv | 2026-06-17 | 2026-06-22 | 5,148,587 | — | $0 | 0 | SEC↗ |
| KARD Kardigan, Inc. | C Conversion deriv | 2026-06-17 | 2026-06-22 | 2,306,401 | — | $0 | 0 | SEC↗ |
| KARD Kardigan, Inc. | C Conversion | 2026-06-17 | 2026-06-22 | 13,792,035 | — | $0 | 13,792,035 | SEC↗ |
| SRRK Scholar Rock Holding Corp | A Award deriv | 2026-06-04 | 2026-06-08 | 4,310 | — | $0 | 4,310 | SEC↗ |
| SRRK Scholar Rock Holding Corp | A Award | 2026-06-04 | 2026-06-08 | 6,839 | — | $0 | 117,710 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | A Award deriv | 2026-05-27 | 2026-05-29 | 80,000 | — | $0 | 80,000 | SEC↗ |
| SPTX Seaport Therapeutics, Inc. | C Conversion deriv | 2026-05-04 | 2026-05-04 | 2,513,686 | — | $0 | 0 | SEC↗ |
| SPTX Seaport Therapeutics, Inc. | C Conversion deriv | 2026-05-04 | 2026-05-04 | 2,681,265 | — | $0 | 0 | SEC↗ |
| SPTX Seaport Therapeutics, Inc. | C Conversion | 2026-05-04 | 2026-05-04 | 2,513,686 | — | $0 | 2,513,686 | SEC↗ |
| SPTX Seaport Therapeutics, Inc. | C Conversion | 2026-05-04 | 2026-05-04 | 2,681,265 | — | $0 | 5,194,951 | SEC↗ |
| SPTX Seaport Therapeutics, Inc. | P Buy | 2026-05-04 | 2026-05-04 | 1,100,000 | $18.00 | $19.80M | 6,294,951 | SEC↗ |
| SRRK Scholar Rock Holding Corp | M Exercise deriv | 2026-04-23 | 2026-04-24 | 7,800 | — | $0 | 0 | SEC↗ |
| SRRK Scholar Rock Holding Corp | M Exercise deriv | 2026-04-23 | 2026-04-24 | 28,000 | — | $0 | 0 | SEC↗ |
| SRRK Scholar Rock Holding Corp | M Exercise deriv | 2026-04-23 | 2026-04-24 | 36,000 | — | $0 | 0 | SEC↗ |
| SRRK Scholar Rock Holding Corp | M Exercise deriv | 2026-04-23 | 2026-04-24 | 18,000 | — | $0 | 0 | SEC↗ |
| SRRK Scholar Rock Holding Corp | M Exercise | 2026-04-23 | 2026-04-24 | 28,000 | $4.75 | $133.0K | 56,871 | SEC↗ |
| SRRK Scholar Rock Holding Corp | M Exercise | 2026-04-23 | 2026-04-24 | 7,800 | $26.78 | $208.9K | 28,871 | SEC↗ |
| SRRK Scholar Rock Holding Corp | M Exercise | 2026-04-23 | 2026-04-24 | 36,000 | $9.11 | $328.0K | 92,871 | SEC↗ |
| SRRK Scholar Rock Holding Corp | M Exercise | 2026-04-23 | 2026-04-24 | 18,000 | $8.36 | $150.5K | 110,871 | SEC↗ |
| LYEL Lyell Immunopharma, Inc. | P Buy | 2026-03-06 | 2026-03-09 | 488,090 | $25.61 | $12.50M | 1,426,528 | SEC↗ |
| MTSR Metsera, Inc. | D To issuer deriv | 2025-11-13 | 2025-11-13 | 148,953 | — | $0 | 0 | SEC↗ |
| MTSR Metsera, Inc. | A Award deriv | 2025-11-13 | 2025-11-13 | 2,688 | — | $0 | 2,688 | SEC↗ |
| MTSR Metsera, Inc. | D To issuer deriv | 2025-11-13 | 2025-11-13 | 16,125 | — | $0 | 0 | SEC↗ |
| MTSR Metsera, Inc. | D To issuer | 2025-11-13 | 2025-11-13 | 2,688 | — | $0 | 0 | SEC↗ |
| MTSR Metsera, Inc. | D To issuer | 2025-11-13 | 2025-11-13 | 17,070,904 | — | $0 | 0 | SEC↗ |
| MTSR Metsera, Inc. | D To issuer | 2025-11-13 | 2025-11-13 | 8,313,680 | — | $0 | 0 | SEC↗ |
| MTSR Metsera, Inc. | D To issuer | 2025-11-13 | 2025-11-13 | 7,523,682 | — | $0 | 0 | SEC↗ |
| MTSR Metsera, Inc. | D To issuer | 2025-11-13 | 2025-11-13 | 18,503,128 | — | $0 | 0 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | P Buy | 2025-10-27 | 2025-10-29 | 1,915,700 | $2.61 | $5.00M | 6,046,907 | SEC↗ |
| PRME Prime Medicine, Inc. | P Buy | 2025-08-01 | 2025-08-01 | 3,030,300 | $3.30 | $10.00M | 6,230,300 | SEC↗ |
| BOLD Boundless Bio, Inc. | A Award deriv | 2025-06-23 | 2025-06-23 | 16,000 | — | $0 | 16,000 | SEC↗ |
| SRRK Scholar Rock Holding Corp | S Sale | 2025-05-29 | 2025-05-30 | 4,400 | $29.83 | $131.3K | 21,071 | SEC↗ |
| SRRK Scholar Rock Holding Corp | S Sale | 2025-05-29 | 2025-05-30 | 1,000 | $29.24 | $29.2K | 25,471 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | A Award deriv | 2025-05-28 | 2025-05-30 | 80,000 | — | $0 | 80,000 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | A Award deriv | 2025-05-28 | 2025-05-30 | 46,455 | — | $0 | 46,455 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | D To issuer deriv | 2025-05-28 | 2025-05-30 | 28,571 | — | $0 | 0 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | D To issuer deriv | 2025-05-28 | 2025-05-30 | 46,455 | — | $0 | 0 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | A Award deriv | 2025-05-28 | 2025-05-30 | 28,571 | — | $0 | 28,571 | SEC↗ |
| SRRK Scholar Rock Holding Corp | A Award deriv | 2025-05-22 | 2025-05-23 | 9,206 | — | $0 | 9,206 | SEC↗ |
| SRRK Scholar Rock Holding Corp | A Award | 2025-05-22 | 2025-05-23 | 7,632 | — | $0 | 26,471 | SEC↗ |
| MTSR Metsera, Inc. | A Award deriv | 2025-05-20 | 2025-05-22 | 16,125 | — | $0 | 16,125 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | D To issuer deriv | 2025-02-13 | 2025-02-18 | 46,455 | — | $0 | 0 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | D To issuer deriv | 2025-02-13 | 2025-02-18 | 28,571 | — | $0 | 0 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | A Award deriv | 2025-02-13 | 2025-02-18 | 46,455 | — | $0 | 46,455 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | A Award deriv | 2025-02-13 | 2025-02-18 | 28,571 | — | $0 | 28,571 | SEC↗ |
| MTSR Metsera, Inc. | C Conversion deriv | 2025-02-03 | 2025-02-03 | 15,000,000 | — | $0 | 0 | SEC↗ |
| MTSR Metsera, Inc. | C Conversion deriv | 2025-02-03 | 2025-02-03 | 19,933,333 | — | $0 | 0 | SEC↗ |
| MTSR Metsera, Inc. | C Conversion deriv | 2025-02-03 | 2025-02-03 | 2,678,571 | — | $0 | 0 | SEC↗ |
| MTSR Metsera, Inc. | C Conversion deriv | 2025-02-03 | 2025-02-03 | 15,000,000 | — | $0 | 0 | SEC↗ |
| MTSR Metsera, Inc. | C Conversion deriv | 2025-02-03 | 2025-02-03 | 2,678,571 | — | $0 | 0 | SEC↗ |
| MTSR Metsera, Inc. | P Buy | 2025-02-03 | 2025-02-03 | 789,998 | $18.00 | $14.22M | 8,313,680 | SEC↗ |
| MTSR Metsera, Inc. | C Conversion | 2025-02-03 | 2025-02-03 | 7,523,682 | — | $0 | 7,523,682 | SEC↗ |
| MTSR Metsera, Inc. | P Buy | 2025-02-03 | 2025-02-03 | 1,432,224 | $18.00 | $25.78M | 18,503,128 | SEC↗ |
| MTSR Metsera, Inc. | C Conversion | 2025-02-03 | 2025-02-03 | 16,006,949 | — | $0 | 17,070,904 | SEC↗ |
| SRRK Scholar Rock Holding Corp | A Award deriv | 2024-06-27 | 2024-07-01 | 18,000 | — | $0 | 18,000 | SEC↗ |
| SRRK Scholar Rock Holding Corp | A Award | 2024-06-27 | 2024-07-01 | 13,500 | — | $0 | 18,839 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | A Award deriv | 2024-06-13 | 2024-06-14 | 28,571 | — | $0 | 28,571 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | A Award | 2024-06-13 | 2024-06-14 | 20,100 | — | $0 | 47,717 | SEC↗ |
| RAPP Rapport Therapeutics, Inc. | C Conversion deriv | 2024-06-10 | 2024-06-10 | 20,000,000 | — | $0 | 0 | SEC↗ |
| RAPP Rapport Therapeutics, Inc. | C Conversion deriv | 2024-06-10 | 2024-06-10 | 11,924,138 | — | $0 | 0 | SEC↗ |
| RAPP Rapport Therapeutics, Inc. | C Conversion | 2024-06-10 | 2024-06-10 | 3,728,738 | — | $0 | 3,728,738 | SEC↗ |
| BOLD Boundless Bio, Inc. | C Conversion deriv | 2024-04-02 | 2024-04-04 | 454,212 | — | $0 | 0 | SEC↗ |
| BOLD Boundless Bio, Inc. | C Conversion deriv | 2024-04-02 | 2024-04-04 | 227,920 | — | $0 | 0 | SEC↗ |
| BOLD Boundless Bio, Inc. | C Conversion deriv | 2024-04-02 | 2024-04-04 | 164,835 | — | $0 | 0 | SEC↗ |
| BOLD Boundless Bio, Inc. | C Conversion deriv | 2024-04-02 | 2024-04-04 | 201,465 | — | $0 | 0 | SEC↗ |
| BOLD Boundless Bio, Inc. | C Conversion deriv | 2024-04-02 | 2024-04-04 | 366,301 | — | $0 | 0 | SEC↗ |
| BOLD Boundless Bio, Inc. | C Conversion deriv | 2024-04-02 | 2024-04-04 | 586,080 | — | $0 | 0 | SEC↗ |
| BOLD Boundless Bio, Inc. | C Conversion deriv | 2024-04-02 | 2024-04-04 | 424,908 | — | $0 | 0 | SEC↗ |
| BOLD Boundless Bio, Inc. | P Buy | 2024-04-02 | 2024-04-04 | 133,333 | $16.00 | $2.13M | 1,181,766 | SEC↗ |
| BOLD Boundless Bio, Inc. | C Conversion | 2024-04-02 | 2024-04-04 | 589,743 | — | $0 | 617,092 | SEC↗ |
| BOLD Boundless Bio, Inc. | C Conversion | 2024-04-02 | 2024-04-04 | 787,545 | — | $0 | 828,570 | SEC↗ |
| BOLD Boundless Bio, Inc. | P Buy | 2024-04-02 | 2024-04-04 | 66,667 | $16.00 | $1.07M | 683,759 | SEC↗ |
| BOLD Boundless Bio, Inc. | C Conversion | 2024-04-02 | 2024-04-04 | 1,048,433 | — | $0 | 1,048,433 | SEC↗ |
| BOLD Boundless Bio, Inc. | A Award deriv | 2024-03-27 | 2024-03-29 | 26,438 | — | $0 | 26,438 | SEC↗ |
| PRME Prime Medicine, Inc. | P Buy | 2024-02-15 | 2024-02-20 | 3,200,000 | $6.25 | $20.00M | 3,200,000 | SEC↗ |
| SANA Sana Biotechnology, Inc. | P Buy | 2024-02-08 | 2024-02-12 | 363,637 | $5.50 | $2.00M | 10,667,387 | SEC↗ |
| SANA Sana Biotechnology, Inc. | P Buy | 2024-02-08 | 2024-02-12 | 727,272 | $5.50 | $4.00M | 12,446,022 | SEC↗ |
| SANA Sana Biotechnology, Inc. | P Buy | 2024-02-08 | 2024-02-12 | 727,272 | $5.50 | $4.00M | 12,446,022 | SEC↗ |
| SRRK Scholar Rock Holding Corp | J Other | 2023-12-21 | 2023-12-26 | 5,339 | — | $0 | 5,339 | SEC↗ |
| SRRK Scholar Rock Holding Corp | J Other | 2023-12-21 | 2023-12-26 | 291,906 | — | $0 | 2,345,711 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | J Other | 2023-12-08 | 2023-12-12 | 1,176,593 | — | $0 | 4,131,207 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | J Other | 2023-12-08 | 2023-12-12 | 13,997 | — | $0 | 27,617 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | J Other | 2023-12-08 | 2023-12-12 | 703,061 | — | $0 | 1,387,228 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | P Buy | 2023-11-14 | 2023-11-15 | 3,357 | $11.98 | $40.2K | 4,131,207 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | P Buy | 2023-11-13 | 2023-11-15 | 31,653 | $11.75 | $371.9K | 4,127,850 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | P Buy | 2023-11-10 | 2023-11-13 | 11,844 | $11.37 | $134.7K | 4,090,766 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | P Buy | 2023-11-10 | 2023-11-13 | 5,431 | $11.75 | $63.8K | 4,096,197 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | P Buy | 2023-11-09 | 2023-11-13 | 31,079 | $10.53 | $327.3K | 4,078,922 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | P Buy | 2023-11-08 | 2023-11-13 | 69,127 | $10.78 | $745.2K | 4,024,719 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | P Buy | 2023-11-08 | 2023-11-13 | 23,124 | $11.79 | $272.6K | 4,047,843 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | P Buy | 2023-11-07 | 2023-11-07 | 30,192 | $11.50 | $347.2K | 3,955,592 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | P Buy | 2023-11-06 | 2023-11-07 | 43,082 | $11.55 | $497.6K | 3,925,400 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | P Buy | 2023-11-03 | 2023-11-07 | 22,420 | $11.38 | $255.1K | 3,882,318 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | P Buy | 2023-09-29 | 2023-09-29 | 34,560 | $13.98 | $483.1K | 3,859,898 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | P Buy | 2023-09-28 | 2023-09-29 | 16,841 | $13.06 | $219.9K | 3,800,228 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | P Buy | 2023-09-28 | 2023-09-29 | 25,110 | $13.69 | $343.8K | 3,825,338 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | P Buy | 2023-09-27 | 2023-09-27 | 24,504 | $12.31 | $301.6K | 3,783,387 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | P Buy | 2023-09-26 | 2023-09-27 | 34,000 | $11.73 | $398.8K | 3,758,883 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | P Buy | 2023-09-25 | 2023-09-25 | 29,967 | $11.65 | $349.1K | 3,724,883 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | P Buy | 2023-09-25 | 2023-09-25 | 30,773 | $10.80 | $332.3K | 3,694,916 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | P Buy | 2023-09-22 | 2023-09-25 | 40,000 | $11.14 | $445.6K | 3,664,143 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | C Conversion deriv | 2023-09-19 | 2023-09-20 | 13,620 | — | $0 | 0 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | C Conversion deriv | 2023-09-19 | 2023-09-20 | 2,124,143 | — | $0 | 0 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | C Conversion deriv | 2023-09-19 | 2023-09-20 | 6,576,400 | — | $0 | 0 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | C Conversion deriv | 2023-09-19 | 2023-09-20 | 684,167 | — | $0 | 0 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | C Conversion deriv | 2023-09-19 | 2023-09-20 | 6,895,021 | — | $0 | 0 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | C Conversion deriv | 2023-09-19 | 2023-09-20 | 1,144,973 | — | $0 | 0 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | P Buy | 2023-09-19 | 2023-09-20 | 1,500,000 | $17.00 | $25.50M | 3,624,143 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | C Conversion | 2023-09-19 | 2023-09-20 | 2,124,143 | — | $0 | 2,124,143 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | C Conversion | 2023-09-19 | 2023-09-20 | 6,576,400 | — | $0 | 11,886,758 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | C Conversion | 2023-09-19 | 2023-09-20 | 6,895,021 | — | $0 | 12,205,379 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | C Conversion | 2023-09-19 | 2023-09-20 | 1,144,973 | — | $0 | 1,144,973 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | C Conversion | 2023-09-19 | 2023-09-20 | 684,167 | — | $0 | 684,167 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | C Conversion | 2023-09-19 | 2023-09-20 | 13,620 | — | $0 | 13,620 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | A Award deriv | 2023-09-14 | 2023-09-18 | 46,455 | — | $0 | 46,455 | SEC↗ |
| DALS DA32 Life Science Tech Acq | J Other | 2023-07-28 | 2023-08-10 | 1,600,000 | — | $0 | 0 | SEC↗ |
| SRRK Scholar Rock Holding Corp | A Award deriv | 2023-06-21 | 2023-06-23 | 36,000 | — | $0 | 36,000 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award deriv | 2023-06-08 | 2023-06-09 | 35,000 | — | $0 | 35,000 | SEC↗ |
| BEAM Beam Therapeutics Inc. | A Award deriv | 2023-06-06 | 2023-06-08 | 16,532 | — | $0 | 16,532 | SEC↗ |
| PRME Prime Medicine, Inc. | C Conversion deriv | 2022-10-24 | 2022-10-26 | 1,141,474 | — | $0 | 0 | SEC↗ |
| PRME Prime Medicine, Inc. | C Conversion deriv | 2022-10-24 | 2022-10-26 | 16,666,667 | — | $0 | 0 | SEC↗ |
| PRME Prime Medicine, Inc. | C Conversion deriv | 2022-10-24 | 2022-10-26 | 16,666,664 | — | $0 | 0 | SEC↗ |
| PRME Prime Medicine, Inc. | C Conversion deriv | 2022-10-24 | 2022-10-26 | 1,141,474 | — | $0 | 0 | SEC↗ |
| PRME Prime Medicine, Inc. | P Buy | 2022-10-24 | 2022-10-26 | 400,000 | $17.00 | $6.80M | 6,128,297 | SEC↗ |
| PRME Prime Medicine, Inc. | C Conversion | 2022-10-24 | 2022-10-26 | 5,728,297 | — | $0 | 5,728,297 | SEC↗ |
| PRME Prime Medicine, Inc. | C Conversion | 2022-10-24 | 2022-10-26 | 5,728,297 | — | $0 | 5,728,297 | SEC↗ |
| PRME Prime Medicine, Inc. | P Buy | 2022-10-24 | 2022-10-26 | 400,000 | $17.00 | $6.80M | 6,128,297 | SEC↗ |
| BEAM Beam Therapeutics Inc. | A Award deriv | 2022-09-01 | 2022-09-02 | 10,391 | — | $0 | 10,391 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award deriv | 2022-06-09 | 2022-07-15 | 30,000 | — | $0 | 30,000 | SEC↗ |
| SRRK Scholar Rock Holding Corp | A Award deriv | 2022-05-26 | 2022-05-27 | 28,000 | — | $0 | 28,000 | SEC↗ |
| DALS DA32 Life Science Tech Acq | J Other deriv | 2021-08-05 | 2021-08-09 | 701,250 | — | $0 | 4,465,000 | SEC↗ |
| DALS DA32 Life Science Tech Acq | J Other | 2021-07-30 | 2021-08-03 | 650,000 | $10.00 | $6.50M | 2,250,000 | SEC↗ |
| DALS DA32 Life Science Tech Acq | P Buy | 2021-07-30 | 2021-08-03 | 1,600,000 | $10.00 | $16.00M | 1,600,000 | SEC↗ |
| ERAS Erasca, Inc. | C Conversion deriv | 2021-07-20 | 2021-07-20 | 2,100,000 | — | $0 | 0 | SEC↗ |
| ERAS Erasca, Inc. | C Conversion deriv | 2021-07-20 | 2021-07-20 | 2,100,000 | — | $0 | 0 | SEC↗ |
| ERAS Erasca, Inc. | C Conversion deriv | 2021-07-20 | 2021-07-20 | 3,400,000 | — | $0 | 0 | SEC↗ |
| ERAS Erasca, Inc. | C Conversion deriv | 2021-07-20 | 2021-07-20 | 1,133,333 | — | $0 | 0 | SEC↗ |
| ERAS Erasca, Inc. | C Conversion deriv | 2021-07-20 | 2021-07-20 | 3,400,000 | — | $0 | 0 | SEC↗ |
| ERAS Erasca, Inc. | C Conversion deriv | 2021-07-20 | 2021-07-20 | 1,133,333 | — | $0 | 0 | SEC↗ |
| ERAS Erasca, Inc. | C Conversion | 2021-07-20 | 2021-07-20 | 5,527,777 | — | $0 | 5,527,777 | SEC↗ |
| ERAS Erasca, Inc. | C Conversion | 2021-07-20 | 2021-07-20 | 5,527,777 | — | $0 | 5,527,777 | SEC↗ |
| BEAM Beam Therapeutics Inc. | J Other | 2021-06-30 | 2021-07-02 | 2,011 | — | $0 | 12,067 | SEC↗ |
| BEAM Beam Therapeutics Inc. | J Other | 2021-06-30 | 2021-07-02 | 200,000 | — | $0 | 2,921,520 | SEC↗ |
| BEAM Beam Therapeutics Inc. | J Other | 2021-06-30 | 2021-07-02 | 200,000 | — | $0 | 2,921,519 | SEC↗ |
| BEAM Beam Therapeutics Inc. | J Other | 2021-06-29 | 2021-06-29 | 200,000 | — | $0 | 3,121,520 | SEC↗ |
| BEAM Beam Therapeutics Inc. | J Other | 2021-06-29 | 2021-06-29 | 2,011 | — | $0 | 10,056 | SEC↗ |
| BEAM Beam Therapeutics Inc. | J Other | 2021-06-29 | 2021-06-29 | 200,000 | — | $0 | 3,121,519 | SEC↗ |
| BEAM Beam Therapeutics Inc. | J Other | 2021-06-25 | 2021-06-29 | 200,000 | — | $0 | 3,321,520 | SEC↗ |
| BEAM Beam Therapeutics Inc. | J Other | 2021-06-25 | 2021-06-29 | 2,011 | — | $0 | 8,045 | SEC↗ |
| BEAM Beam Therapeutics Inc. | J Other | 2021-06-25 | 2021-06-29 | 200,000 | — | $0 | 3,321,519 | SEC↗ |
| UBX Unity Biotechnology, Inc. | A Award deriv | 2021-06-24 | 2021-06-28 | 25,000 | — | $0 | 25,000 | SEC↗ |
| VERV Verve Therapeutics, Inc. | C Conversion deriv | 2021-06-21 | 2021-06-23 | 7,107,024 | — | $0 | 0 | SEC↗ |
| VERV Verve Therapeutics, Inc. | C Conversion deriv | 2021-06-21 | 2021-06-23 | 7,107,023 | — | $0 | 0 | SEC↗ |
| VERV Verve Therapeutics, Inc. | C Conversion deriv | 2021-06-21 | 2021-06-23 | 4,508,144 | — | $0 | 0 | SEC↗ |
| VERV Verve Therapeutics, Inc. | C Conversion deriv | 2021-06-21 | 2021-06-23 | 4,508,146 | — | $0 | 0 | SEC↗ |
| VERV Verve Therapeutics, Inc. | C Conversion | 2021-06-21 | 2021-06-23 | 1,254,404 | — | $0 | 1,254,404 | SEC↗ |
| VERV Verve Therapeutics, Inc. | C Conversion | 2021-06-21 | 2021-06-23 | 1,254,405 | — | $0 | 1,254,405 | SEC↗ |
| BEAM Beam Therapeutics Inc. | A Award deriv | 2021-06-10 | 2021-06-14 | 6,877 | — | $0 | 6,877 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award deriv | 2021-06-09 | 2021-06-10 | 23,500 | — | $0 | 23,500 | SEC↗ |
| SRRK Scholar Rock Holding Corp | A Award deriv | 2021-05-27 | 2021-06-01 | 7,800 | — | $0 | 7,800 | SEC↗ |
| MTCR Metacrine, Inc. | A Award deriv | 2021-05-24 | 2021-05-25 | 16,500 | — | $0 | 16,500 | SEC↗ |
| BEAM Beam Therapeutics Inc. | J Other | 2021-03-31 | 2021-04-02 | 200,000 | — | $0 | 3,521,519 | SEC↗ |
| BEAM Beam Therapeutics Inc. | J Other | 2021-03-31 | 2021-04-02 | 2,011 | — | $0 | 6,034 | SEC↗ |
| BEAM Beam Therapeutics Inc. | J Other | 2021-03-31 | 2021-04-02 | 200,000 | — | $0 | 3,521,520 | SEC↗ |
| BEAM Beam Therapeutics Inc. | J Other | 2021-03-22 | 2021-03-22 | 200,000 | — | $0 | 3,721,519 | SEC↗ |
| BEAM Beam Therapeutics Inc. | J Other | 2021-03-22 | 2021-03-22 | 200,000 | — | $0 | 3,721,520 | SEC↗ |
| BEAM Beam Therapeutics Inc. | J Other | 2021-03-22 | 2021-03-22 | 2,011 | — | $0 | 4,023 | SEC↗ |
| BEAM Beam Therapeutics Inc. | J Other | 2021-03-18 | 2021-03-22 | 200,000 | — | $0 | 3,921,519 | SEC↗ |
| BEAM Beam Therapeutics Inc. | J Other | 2021-03-18 | 2021-03-22 | 200,000 | — | $0 | 3,921,520 | SEC↗ |
| BEAM Beam Therapeutics Inc. | J Other | 2021-03-18 | 2021-03-22 | 2,012 | — | $0 | 2,012 | SEC↗ |
| SANA Sana Biotechnology, Inc. | C Conversion deriv | 2021-02-08 | 2021-02-10 | 5,687,500 | — | $0 | 0 | SEC↗ |
| SANA Sana Biotechnology, Inc. | C Conversion deriv | 2021-02-08 | 2021-02-10 | 3,687,500 | — | $0 | 0 | SEC↗ |
| SANA Sana Biotechnology, Inc. | C Conversion deriv | 2021-02-08 | 2021-02-10 | 2,343,750 | — | $0 | 0 | SEC↗ |
| SANA Sana Biotechnology, Inc. | C Conversion deriv | 2021-02-08 | 2021-02-10 | 2,343,750 | — | $0 | 0 | SEC↗ |
| SANA Sana Biotechnology, Inc. | C Conversion deriv | 2021-02-08 | 2021-02-10 | 781,250 | — | $0 | 0 | SEC↗ |
| SANA Sana Biotechnology, Inc. | C Conversion deriv | 2021-02-08 | 2021-02-10 | 781,250 | — | $0 | 0 | SEC↗ |
| SANA Sana Biotechnology, Inc. | C Conversion deriv | 2021-02-08 | 2021-02-10 | 9,375,000 | — | $0 | 0 | SEC↗ |
| SANA Sana Biotechnology, Inc. | C Conversion deriv | 2021-02-08 | 2021-02-10 | 9,375,000 | — | $0 | 0 | SEC↗ |
| SANA Sana Biotechnology, Inc. | C Conversion deriv | 2021-02-08 | 2021-02-10 | 5,687,500 | — | $0 | 0 | SEC↗ |
| SANA Sana Biotechnology, Inc. | C Conversion deriv | 2021-02-08 | 2021-02-10 | 3,687,500 | — | $0 | 0 | SEC↗ |
| SANA Sana Biotechnology, Inc. | C Conversion | 2021-02-08 | 2021-02-10 | 10,156,250 | — | $0 | 10,303,750 | SEC↗ |
| SANA Sana Biotechnology, Inc. | C Conversion | 2021-02-08 | 2021-02-10 | 11,718,750 | — | $0 | 11,718,750 | SEC↗ |
| SANA Sana Biotechnology, Inc. | C Conversion | 2021-02-08 | 2021-02-10 | 11,718,750 | — | $0 | 11,718,750 | SEC↗ |
| SANA Sana Biotechnology, Inc. | C Conversion | 2021-02-08 | 2021-02-10 | 10,156,250 | — | $0 | 10,301,250 | SEC↗ |
| MTCR Metacrine, Inc. | C Conversion deriv | 2020-09-18 | 2020-09-22 | 138,734 | — | $0 | 0 | SEC↗ |
| MTCR Metacrine, Inc. | C Conversion deriv | 2020-09-18 | 2020-09-22 | 138,734 | — | $0 | 0 | SEC↗ |
| MTCR Metacrine, Inc. | C Conversion deriv | 2020-09-18 | 2020-09-22 | 472,251 | — | $0 | 0 | SEC↗ |
| MTCR Metacrine, Inc. | C Conversion deriv | 2020-09-18 | 2020-09-22 | 1,960,784 | — | $0 | 0 | SEC↗ |
| MTCR Metacrine, Inc. | C Conversion | 2020-09-18 | 2020-09-22 | 138,734 | — | $0 | 138,734 | SEC↗ |
| MTCR Metacrine, Inc. | P Buy | 2020-09-18 | 2020-09-22 | 20,000 | $13.00 | $260.0K | 158,734 | SEC↗ |
| MTCR Metacrine, Inc. | C Conversion | 2020-09-18 | 2020-09-22 | 1,960,784 | — | $0 | 1,960,784 | SEC↗ |
| MTCR Metacrine, Inc. | C Conversion | 2020-09-18 | 2020-09-22 | 472,251 | — | $0 | 2,433,035 | SEC↗ |
| MTCR Metacrine, Inc. | C Conversion | 2020-09-18 | 2020-09-22 | 138,734 | — | $0 | 2,571,769 | SEC↗ |
| MTCR Metacrine, Inc. | P Buy | 2020-09-18 | 2020-09-22 | 210,000 | $13.00 | $2.73M | 2,781,769 | SEC↗ |
| UBX Unity Biotechnology, Inc. | A Award deriv | 2020-06-18 | 2020-06-22 | 25,000 | — | $0 | 25,000 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award deriv | 2020-06-17 | 2020-06-18 | 23,500 | — | $0 | 23,500 | SEC↗ |
| SRRK Scholar Rock Holding Corp | A Award deriv | 2020-06-16 | 2020-06-18 | 13,000 | — | $0 | 13,000 | SEC↗ |
| VIR Vir Biotechnology, Inc. | A Award deriv | 2020-05-21 | 2020-10-13 | 25,404 | — | $0 | 25,404 | SEC↗ |
| VIR Vir Biotechnology, Inc. | A Award deriv | 2020-05-21 | 2020-05-26 | 28,888 | — | $0 | 28,888 | SEC↗ |
| BEAM Beam Therapeutics Inc. | C Conversion deriv | 2020-02-10 | 2020-02-11 | 1,338,000 | — | $0 | 0 | SEC↗ |
| BEAM Beam Therapeutics Inc. | C Conversion deriv | 2020-02-10 | 2020-02-11 | 1,338,000 | — | $0 | 0 | SEC↗ |
| BEAM Beam Therapeutics Inc. | C Conversion deriv | 2020-02-10 | 2020-02-11 | 2,750,336 | — | $0 | 0 | SEC↗ |
| BEAM Beam Therapeutics Inc. | C Conversion deriv | 2020-02-10 | 2020-02-11 | 33,184 | — | $0 | 0 | SEC↗ |
| BEAM Beam Therapeutics Inc. | C Conversion deriv | 2020-02-10 | 2020-02-11 | 33,184 | — | $0 | 0 | SEC↗ |
| BEAM Beam Therapeutics Inc. | C Conversion deriv | 2020-02-10 | 2020-02-11 | 2,750,335 | — | $0 | 0 | SEC↗ |
| BEAM Beam Therapeutics Inc. | C Conversion | 2020-02-10 | 2020-02-11 | 4,121,519 | — | $0 | 4,121,519 | SEC↗ |
| BEAM Beam Therapeutics Inc. | C Conversion | 2020-02-10 | 2020-02-11 | 4,121,520 | — | $0 | 4,121,520 | SEC↗ |
| VIR Vir Biotechnology, Inc. | C Conversion deriv | 2019-10-16 | 2019-10-18 | 11,111,110 | — | $0 | 0 | SEC↗ |
| VIR Vir Biotechnology, Inc. | C Conversion deriv | 2019-10-16 | 2019-10-18 | 555,555 | — | $0 | 0 | SEC↗ |
| VIR Vir Biotechnology, Inc. | C Conversion deriv | 2019-10-16 | 2019-10-18 | 2,222,222 | — | $0 | 0 | SEC↗ |
| VIR Vir Biotechnology, Inc. | C Conversion deriv | 2019-10-16 | 2019-10-18 | 13,333,332 | — | $0 | 0 | SEC↗ |
| VIR Vir Biotechnology, Inc. | C Conversion | 2019-10-16 | 2019-10-18 | 11,666,665 | — | $0 | 12,111,109 | SEC↗ |
| VIR Vir Biotechnology, Inc. | P Buy | 2019-10-16 | 2019-10-18 | 1,000,000 | $20.00 | $20.00M | 1,000,000 | SEC↗ |
| VIR Vir Biotechnology, Inc. | C Conversion | 2019-10-16 | 2019-10-18 | 15,555,554 | — | $0 | 15,555,554 | SEC↗ |
| UBX Unity Biotechnology, Inc. | A Award deriv | 2019-06-20 | 2019-06-24 | 25,000 | — | $0 | 25,000 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award deriv | 2019-06-10 | 2019-06-11 | 23,500 | — | $0 | 23,500 | SEC↗ |
| SNNA Sienna Biopharmaceuticals, | A Award deriv | 2019-05-30 | 2019-06-03 | 25,000 | — | $0 | 25,000 | SEC↗ |
| SRRK Scholar Rock Holding Corp | A Award deriv | 2019-05-21 | 2019-05-23 | 10,158 | — | $0 | 10,158 | SEC↗ |
| SNNA Sienna Biopharmaceuticals, | P Buy | 2019-02-22 | 2019-02-26 | 150,000 | $2.50 | $375.0K | 1,032,493 | SEC↗ |
| SNNA Sienna Biopharmaceuticals, | P Buy | 2019-02-22 | 2019-02-26 | 150,000 | $2.50 | $375.0K | 2,900,575 | SEC↗ |
| SNNA Sienna Biopharmaceuticals, | P Buy | 2019-02-22 | 2019-02-26 | 1,865,800 | $2.50 | $4.66M | 1,865,800 | SEC↗ |
| GOSS Gossamer Bio, Inc. | C Conversion deriv | 2019-02-12 | 2019-02-12 | 1,554,388 | — | $0 | 0 | SEC↗ |
| GOSS Gossamer Bio, Inc. | C Conversion deriv | 2019-02-12 | 2019-02-12 | 16,571,429 | — | $0 | 0 | SEC↗ |
| GOSS Gossamer Bio, Inc. | C Conversion deriv | 2019-02-12 | 2019-02-12 | 1,554,388 | — | $0 | 0 | SEC↗ |
| GOSS Gossamer Bio, Inc. | C Conversion deriv | 2019-02-12 | 2019-02-12 | 16,571,428 | — | $0 | 0 | SEC↗ |
| GOSS Gossamer Bio, Inc. | C Conversion | 2019-02-12 | 2019-02-12 | 345,419 | — | $0 | 4,027,958 | SEC↗ |
| GOSS Gossamer Bio, Inc. | C Conversion | 2019-02-12 | 2019-02-12 | 3,682,539 | — | $0 | 3,682,539 | SEC↗ |
| GOSS Gossamer Bio, Inc. | C Conversion | 2019-02-12 | 2019-02-12 | 345,419 | — | $0 | 4,027,958 | SEC↗ |
| GOSS Gossamer Bio, Inc. | C Conversion | 2019-02-12 | 2019-02-12 | 3,682,539 | — | $0 | 3,682,539 | SEC↗ |
| SRRK Scholar Rock Holding Corp | A Award deriv | 2018-06-22 | 2018-06-26 | 20,316 | — | $0 | 20,316 | SEC↗ |
| SNNA Sienna Biopharmaceuticals, | A Award deriv | 2018-06-01 | 2018-06-05 | 10,000 | — | $0 | 10,000 | SEC↗ |
| SRRK Scholar Rock Holding Corp | C Conversion deriv | 2018-05-29 | 2018-05-31 | 838,780 | — | $0 | 0 | SEC↗ |
| SRRK Scholar Rock Holding Corp | C Conversion deriv | 2018-05-29 | 2018-05-31 | 1,249,999 | — | $0 | 0 | SEC↗ |
| SRRK Scholar Rock Holding Corp | C Conversion deriv | 2018-05-29 | 2018-05-31 | 2,054,197 | — | $0 | 0 | SEC↗ |
| SRRK Scholar Rock Holding Corp | C Conversion deriv | 2018-05-29 | 2018-05-31 | 1,575,299 | — | $0 | 0 | SEC↗ |
| SRRK Scholar Rock Holding Corp | C Conversion deriv | 2018-05-29 | 2018-05-31 | 1,811,595 | — | $0 | 0 | SEC↗ |
| SRRK Scholar Rock Holding Corp | C Conversion | 2018-05-29 | 2018-05-31 | 719,559 | — | $0 | 2,343,804 | SEC↗ |
| SRRK Scholar Rock Holding Corp | C Conversion | 2018-05-29 | 2018-05-31 | 293,813 | — | $0 | 2,637,617 | SEC↗ |
| SRRK Scholar Rock Holding Corp | C Conversion | 2018-05-29 | 2018-05-31 | 437,859 | — | $0 | 437,859 | SEC↗ |
| SRRK Scholar Rock Holding Corp | C Conversion | 2018-05-29 | 2018-05-31 | 634,579 | — | $0 | 1,072,438 | SEC↗ |
| SRRK Scholar Rock Holding Corp | C Conversion | 2018-05-29 | 2018-05-31 | 551,807 | — | $0 | 1,624,245 | SEC↗ |
| UBX Unity Biotechnology, Inc. | C Conversion deriv | 2018-05-07 | 2018-05-07 | 1,486,745 | — | $0 | 0 | SEC↗ |
| UBX Unity Biotechnology, Inc. | C Conversion deriv | 2018-05-07 | 2018-05-07 | 195,672 | — | $0 | 0 | SEC↗ |
| UBX Unity Biotechnology, Inc. | C Conversion deriv | 2018-05-07 | 2018-05-07 | 2,067,160 | — | $0 | 0 | SEC↗ |
| UBX Unity Biotechnology, Inc. | C Conversion deriv | 2018-05-07 | 2018-05-07 | 2,030,625 | — | $0 | 0 | SEC↗ |
| UBX Unity Biotechnology, Inc. | C Conversion deriv | 2018-05-07 | 2018-05-07 | 4,228,432 | — | $0 | 0 | SEC↗ |
| UBX Unity Biotechnology, Inc. | C Conversion | 2018-05-07 | 2018-05-07 | 195,672 | — | $0 | 1,682,417 | SEC↗ |
| UBX Unity Biotechnology, Inc. | C Conversion | 2018-05-07 | 2018-05-07 | 1,486,745 | — | $0 | 1,486,745 | SEC↗ |
| UBX Unity Biotechnology, Inc. | C Conversion | 2018-05-07 | 2018-05-07 | 2,067,160 | — | $0 | 8,365,764 | SEC↗ |
| UBX Unity Biotechnology, Inc. | C Conversion | 2018-05-07 | 2018-05-07 | 4,228,432 | — | $0 | 6,298,604 | SEC↗ |
| UBX Unity Biotechnology, Inc. | C Conversion | 2018-05-07 | 2018-05-07 | 2,030,625 | — | $0 | 2,070,172 | SEC↗ |
| UBX Unity Biotechnology, Inc. | A Award deriv | 2018-05-02 | 2018-05-04 | 40,678 | — | $0 | 40,678 | SEC↗ |
| SNNA Sienna Biopharmaceuticals, | A Award deriv | 2017-11-01 | 2017-11-02 | 5,315 | — | $0 | 5,315 | SEC↗ |
| SNNA Sienna Biopharmaceuticals, | C Conversion deriv | 2017-08-01 | 2017-08-01 | 319,421 | — | $0 | 0 | SEC↗ |
| SNNA Sienna Biopharmaceuticals, | C Conversion deriv | 2017-08-01 | 2017-08-01 | 211,934 | — | $0 | 0 | SEC↗ |
| SNNA Sienna Biopharmaceuticals, | C Conversion deriv | 2017-08-01 | 2017-08-01 | 563,072 | — | $0 | 0 | SEC↗ |
| SNNA Sienna Biopharmaceuticals, | C Conversion deriv | 2017-08-01 | 2017-08-01 | 2,538,641 | — | $0 | 0 | SEC↗ |
| SNNA Sienna Biopharmaceuticals, | C Conversion | 2017-08-01 | 2017-08-01 | 211,934 | — | $0 | 2,750,575 | SEC↗ |
| SNNA Sienna Biopharmaceuticals, | C Conversion | 2017-08-01 | 2017-08-01 | 2,538,641 | — | $0 | 2,538,641 | SEC↗ |
| SNNA Sienna Biopharmaceuticals, | C Conversion | 2017-08-01 | 2017-08-01 | 319,421 | — | $0 | 882,493 | SEC↗ |
| SNNA Sienna Biopharmaceuticals, | C Conversion | 2017-08-01 | 2017-08-01 | 563,072 | — | $0 | 563,072 | SEC↗ |
| RCPT Receptos, Inc. | D To issuer deriv | 2015-08-27 | 2015-08-27 | 18,800 | $213.23 | $4.01M | 0 | SEC↗ |
| RCPT Receptos, Inc. | D To issuer deriv | 2015-08-27 | 2015-08-27 | 9,400 | $204.56 | $1.92M | 0 | SEC↗ |
| RCPT Receptos, Inc. | D To issuer | 2015-08-27 | 2015-08-27 | 7,400 | — | $0 | 0 | SEC↗ |
| RCPT Receptos, Inc. | U Tender | 2015-08-25 | 2015-08-27 | 18,346 | — | $0 | 7,400 | SEC↗ |